Kyowa Kirin Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Kyowa Kirin Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Kyowa Kirin Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Kyowa Kirin Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Kyowa Kirin Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Kyowa Kirin Co Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Masashi Miyamoto, PhD
Chairman Executive BoardDr. Masashi Miyamoto has been the Chairman of the company since 2025. Prior to this, he served as the Representative Director, President, and Chief Executive Officer of the company, Chief Operating Officer, Managing Executive Officer, and Strategic Product Portfolio Department of the company. Mr. Miyamoto also served as the Manager, Regulatory Affairs Department of Pharmacovigilance and Quality Assurance Division; Deputy Director, Corporate Strategy & Planning Department at Kyowa Hakko Kirin Co Ltd.
Abdul Mullick, PhD
President; Chief Executive Officer; Director Executive BoardMr. Abdul Mullick has been the Director, President, and Chief Executive Officer of the company since March 2026. Prior to this, he served as the Chief International Business Officer and Managing Executive Officer of the company; Vice Chief International Business Officer and Managing Executive Officer for the company; and as the President of the company.
Takeyoshi Yamashita, PhD
Chief Scientific Officer; Director; Executive Vice President Executive BoardDr. Takeyoshi Yamashita has been the Chief Scientific Officer, Director, and Executive Vice President of the company since March 2026. Prior to this, he served as the Director, Senior Managing Executive Officer, and Chief Medical Officer of the company; and Director and Head of the Corporate Strategy and Planning Department of the company. Dr. Yamashita has also served as the Executive Officer, Director, Corporate Strategy and Planning Department in Kyowa Hakko Kirin Co Ltd, and as the Executive Officer and Director in the Regulatory Affairs Department of the company.
Koji Igarashi
Chief Financial Officer Senior ManagementMr. Koji Igarashi has been the Chief Financial Officer of the company since March 2026. Prior to this, he served as the Chief Financial Officer and Senior Vice President, Japan Business Unit at Takeda Pharmaceutical Company Limited. Previously, he served as the Global Head & Vice President, Corporate Planning & Analysis, Takeda Pharmaceutical Company Limited.
Colin Sims
Chief Strategy Officer Senior ManagementMr. Colin Sims has been the Chief Strategy Officer of the company since April 2026. Prior to this, he served as the Chief Executive Officer and Founding Partner at Sapientia Advisory Partners. Previously, he served as the Chief Executive Officer of Adthera Bio Limited Ltd. Mr. Sims also served as the Managing Partner at Delin Life Science Ventures.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer